BioRestorative Therapies
Price & Volume
Stats
See more52W Range | $1.03-$2.55 |
Market Cap | $13.6M |
Shares Short | 234,048 |
Financials
See moreRevenue (12 Mos) | $377,000 |
Revenue Growth (YoY) | 660.9% |
Gross Profit (12 Mos) | $352,267 |
Diluted EPS | -$2.38 |
News
See moreYahoo Finance • 5 days ago
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
Yahoo Finance • 26 days ago
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
Yahoo Finance • 27 days ago
BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
Yahoo Finance • last month
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
About
CEO | Mr. Lance Alstodt |
Address | 40 Marcus Drive, Melville, NY, United States, 11747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
